Childrens Medical Center Corporation;Children's Medical Center Corporation
发明人:
Watnick, Randolph
申请号：
AU2018201649
公开号：
AU2018201649A1
申请日:
2018.03.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018201649A120180329.pdf#####ABSTRACT 104641 The invention relates to isolated peptides and chimeric polypeptides derived from Saposin A that have anti-angiogenic activity. These peptides are small, consisting essentially of at least 10 consecutive amino acid residues from the 3 1"-5 0" amino acid residue of Saposin A. The invention also relates to the use of these isolated peptides and chimeric polypeptides in compositions for the treatment, prevention, and inhibition of angiogenesis-related diseases and disorders such as cancer and cancer metastasis.
